Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies ...

Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.

SS Innovations International, an Indian surgical robotics company, is set to list on the Nasdaq under the ticker 'SSII' on ...

Novavax Inc. research and ratings by Barron's. View NVAX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

The US stock market has been flirting with a bear market recently, but has yet to cross the Rubicon. Click to read.

INVO Fertility (IVF), formerly known as NAYA Biosciences (NAYA), confirmed it will begin trading under the new symbol “IVF” at the market open ...

Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, April 23: Casella ...

Here are two stocks with buy rank and strong value characteristics for investors to consider today, April 23: Phio ...

The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The Zacks Consensus Estimate for revenues is pegged at $3.25 billion, while the ...